227 Results

People

  1. Motzer
    Motzer
  2. Scher
    Scher
  3. Amar
    Amar
  4. Norton
    Norton
  5. Kris
    Kris
  6. Morris
    Morris
  7. Mulhall
    Mulhall
  8. Papanicolaou
    Papanicolaou
  9. Tap
    Tap
  10. Aghajanian
    Aghajanian

Groups

  1. Department of Medicine (128)
  2. Solid Tumor Oncology Division (97)
  3. Surgery (34)
  4. Survivorship Research (33)
  5. Genitourinary Oncology Service (27)
  6. Division of Subspecialty Medicine (23)
  7. Population Sciences Research Program (20)
  8. Epidemiology and Biostatistics (18)
  9. Hematologic Malignancies, Division of (18)
  10. Breast Medicine Service (17)
  1. "double blind procedure"
Formats
  1. Journal Article (219)
  2. Conference Paper (3)
  3. Correspondence (3)
  4. Editorial (1)
  5. Review (1)
Groups
  1. Department of Medicine (128)
  2. Solid Tumor Oncology Division (97)
  3. Surgery (34)
  4. Survivorship Research (33)
  5. Genitourinary Oncology Service (27)
  6. Division of Subspecialty Medicine (23)

More Groups

People
  1. Howard Scher (10)
  2. Robert Motzer (10)
  3. David Amar (7)
  4. Jose Baselga (7)
  5. Larry Norton (7)
  6. Genovefa Papanicolaou (6)

More People

Years
  1. 2025 (4)
  2. 2024 (21)
  3. 2023 (13)
  4. 2022 (12)
  5. 2021 (5)
  6. 2020 (10)

More Years

Publications
  1. Journal of Clinical Oncology (21)
  2. Lancet Oncology (20)
  3. New England Journal of Medicine (17)
  4. Clinical Cancer Research (9)
  5. Lancet (8)
  6. Annals of Oncology (6)

More Publications

Publishers
  1. Elsevier Science, Inc. (37)
  2. Elsevier Inc. (28)
  3. American Society of Clinical Oncology (21)
  4. Oxford University Press (19)
  5. Lippincott Williams & Wilkins (17)
  6. Massachusetts Medical Society (17)

More Publishers

Results (227)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Xerosis and pruritus as major EGFRI-associated adverse events
    Journal Article

    Clabbers, J. M. K.; Boers-Doets, C. B.; Gelderblom, H.; Stijnen, T.; Lacouture, M. E.; van der Hoeven, K. J. M.; Kaptein, A. A.
    Supportive Care in Cancer (2016)

    Fulltext@MSK | Save
  • Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): A randomised, double-blind, phase 3 trial
    Journal Article

    Eggermont, A. M. M.; Chiarion-Sileni, V.; Grob, J. J.; Dummer, R.; Wolchok, J. D.; Schmidt, H.; Hamid, O.; Robert, C.; Ascierto, P. A.; Richards, J. M.; more...
    Lancet Oncology (2015)

    Fulltext@MSK | Save
  • Impact of cardiovascular risk factors and related comorbid conditions and medical therapy reported at baseline on the treatment response to tadalafil 5 mg once-daily in men with lower urinary tract symptoms associated with benign prostatic hyperplasia: An integrated analysis of four randomised, double-blind, placebo-controlled, clinical trials
    Journal Article

    Vlachopoulos, C.; Oelke, M.; Maggi, M.; Mulhall, J. P.; Rosenberg, M. T.; Brock, G. B.; Esler, A.; Büttner, H.
    International Journal of Clinical Practice (2015)

    Fulltext@MSK | Save
  • Development and validation of a prognostic nomogram for progression-free survival in patients with advanced renal cell carcinoma treated with pazopanib
    Journal Article

    Kattan, M. W.; Sternberg, C. N.; Mehmud, F.; Bhatt, K.; McCann, L.; Motzer, R. J.
    Oncology (2015)

    Fulltext@MSK | Save
  • Efficacy and safety of abiraterone acetate in elderly (75 years or older) chemotherapy naïve patients with metastatic castration resistant prostate cancer
    Journal Article

    Smith, M. R.; Rathkopf, D. E.; Mulders, P. F. A.; Carles, J.; Van Poppel, H.; Li, J.; Kheoh, T.; Griffin, T. W.; Molina, A.; Ryan, C. J.
    Journal of Urology (2015)

    Fulltext@MSK | Save
  • Double-blind randomized 12-month soy intervention had no effects on breast MRI fibroglandular tissue density or mammographic density
    Journal Article

    Wu, A. H.; Spicer, D.; Garcia, A.; Tseng, C. C.; Hovanessian-Larsen, L.; Sheth, P.; Martin, S. E.; Hawes, D.; Russell, C.; MacDonald, H.; more...
    Cancer Prevention Research (2015)

    Fulltext@MSK | Save
  • Vosaroxin plus cytarabine versus placebo plus cytarabine in patients with first relapsed or refractory acute myeloid leukaemia (VALOR): A randomised, controlled, double-blind, multinational, phase 3 study
    Journal Article

    Ravandi, F.; Ritchie, E. K.; Sayar, H.; Lancet, J. E.; Craig, M. D.; Vey, N.; Strickland, S. A.; Schiller, G. J.; Jabbour, E.; Erba, H. P.; more...
    Lancet Oncology (2015)

    Fulltext@MSK | Save
  • Beneficial effects of perioperative statins for major pulmonary resection
    Journal Article

    Amar, D.; Park, B.; Zhang, H.; Shi, W.; Fleisher, M.; Thaler, H. T.; Rusch, V. W.
    Journal of Thoracic and Cardiovascular Surgery (2015)

    Fulltext@MSK | Save
  • IL8 polymorphisms and overall survival in pazopanib- or sunitinib-treated patients with renal cell carcinoma
    Journal Article

    Xu, C. F.; Johnson, T.; Garcia-Donas, J.; Choueiri, T. K.; Sternberg, C. N.; Davis, I. D.; Bing, N.; Deen, K. C.; Xue, Z.; McCann, L.; more...
    British Journal of Cancer (2015)

    Fulltext@MSK | Save
  • Effect of tadalafil once daily on penile length loss and morning erections in patients after bilateral nerve-sparing radical prostatectomy: Results from a randomized controlled trial
    Journal Article

    Brock, G.; Montorsi, F.; Costa, P.; Shah, N.; Martinez-Jabaloyas, J. M.; Hammerer, P.; Ludovico, G. M.; Lee, J. C.; Henneges, C.; Hamidi, K.; more...
    Urology (2015)

    Fulltext@MSK | Save